SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 151 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $2,284,000 | -46.1% | 222,827 | -31.4% | 0.02% | -50.0% |
Q2 2016 | $4,240,000 | -16.1% | 324,651 | -29.4% | 0.03% | -25.0% |
Q1 2016 | $5,056,000 | +13.3% | 459,607 | -5.2% | 0.04% | 0.0% |
Q4 2015 | $4,461,000 | +61.3% | 484,848 | +21.7% | 0.04% | +53.8% |
Q3 2015 | $2,765,000 | – | 398,426 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,249,200 | $13,491,000 | 8.04% |
Nantahala Capital Management | 2,169,043 | $23,426,000 | 2.43% |
Sensato Investors LLC | 429,069 | $4,634,000 | 0.80% |
TFS CAPITAL LLC | 144,575 | $1,561,000 | 0.42% |
Sapphire Star Partners LP | 27,938 | $302,000 | 0.34% |
Ativo Capital Management LLC | 123,428 | $1,333,000 | 0.31% |
Zebra Capital Management LLC | 55,618 | $601,000 | 0.18% |
MENTA CAPITAL LLC | 191,474 | $2,068,000 | 0.17% |
GSA CAPITAL PARTNERS LLP | 231,214 | $2,497,000 | 0.15% |
ACADIAN ASSET MANAGEMENT LLC | 1,919,172 | $20,729,000 | 0.10% |